Such findings broaden mechanistic knowledge on EV-mediated immune checkpoint regulation in MM, and the results here described complement previous studies where the role of soluble HLA-G in tumor burden and disease progression was suggested as a potential biomarker for disease monitoring and risk stratification (7, 65). This evidence concerns the gene HLA-G and neoplasm.